S&P 500   3,634.45 (+1.59%)
DOW   30,034.98 (+1.50%)
QQQ   294.47 (+1.41%)
AAPL   115.27 (+1.25%)
MSFT   213.08 (+1.41%)
FB   277.40 (+3.34%)
GOOGL   1,763.31 (+2.07%)
AMZN   3,116.11 (+0.57%)
TSLA   554.73 (+6.30%)
NVDA   516.57 (-1.72%)
BABA   279.65 (+3.53%)
CGC   26.90 (+8.82%)
GE   10.47 (+3.97%)
MU   63.88 (-0.47%)
AMD   84.97 (-0.40%)
T   29.20 (+2.03%)
NIO   53.56 (-3.29%)
F   9.42 (+6.32%)
ACB   9.05 (+26.04%)
NFLX   482.90 (+1.32%)
GILD   60.29 (+0.67%)
BA   217.95 (+3.04%)
DIS   151.39 (+3.71%)
S&P 500   3,634.45 (+1.59%)
DOW   30,034.98 (+1.50%)
QQQ   294.47 (+1.41%)
AAPL   115.27 (+1.25%)
MSFT   213.08 (+1.41%)
FB   277.40 (+3.34%)
GOOGL   1,763.31 (+2.07%)
AMZN   3,116.11 (+0.57%)
TSLA   554.73 (+6.30%)
NVDA   516.57 (-1.72%)
BABA   279.65 (+3.53%)
CGC   26.90 (+8.82%)
GE   10.47 (+3.97%)
MU   63.88 (-0.47%)
AMD   84.97 (-0.40%)
T   29.20 (+2.03%)
NIO   53.56 (-3.29%)
F   9.42 (+6.32%)
ACB   9.05 (+26.04%)
NFLX   482.90 (+1.32%)
GILD   60.29 (+0.67%)
BA   217.95 (+3.04%)
DIS   151.39 (+3.71%)
S&P 500   3,634.45 (+1.59%)
DOW   30,034.98 (+1.50%)
QQQ   294.47 (+1.41%)
AAPL   115.27 (+1.25%)
MSFT   213.08 (+1.41%)
FB   277.40 (+3.34%)
GOOGL   1,763.31 (+2.07%)
AMZN   3,116.11 (+0.57%)
TSLA   554.73 (+6.30%)
NVDA   516.57 (-1.72%)
BABA   279.65 (+3.53%)
CGC   26.90 (+8.82%)
GE   10.47 (+3.97%)
MU   63.88 (-0.47%)
AMD   84.97 (-0.40%)
T   29.20 (+2.03%)
NIO   53.56 (-3.29%)
F   9.42 (+6.32%)
ACB   9.05 (+26.04%)
NFLX   482.90 (+1.32%)
GILD   60.29 (+0.67%)
BA   217.95 (+3.04%)
DIS   151.39 (+3.71%)
S&P 500   3,634.45 (+1.59%)
DOW   30,034.98 (+1.50%)
QQQ   294.47 (+1.41%)
AAPL   115.27 (+1.25%)
MSFT   213.08 (+1.41%)
FB   277.40 (+3.34%)
GOOGL   1,763.31 (+2.07%)
AMZN   3,116.11 (+0.57%)
TSLA   554.73 (+6.30%)
NVDA   516.57 (-1.72%)
BABA   279.65 (+3.53%)
CGC   26.90 (+8.82%)
GE   10.47 (+3.97%)
MU   63.88 (-0.47%)
AMD   84.97 (-0.40%)
T   29.20 (+2.03%)
NIO   53.56 (-3.29%)
F   9.42 (+6.32%)
ACB   9.05 (+26.04%)
NFLX   482.90 (+1.32%)
GILD   60.29 (+0.67%)
BA   217.95 (+3.04%)
DIS   151.39 (+3.71%)
Log in
LON:SPH

Sinclair Pharma plc (SPH.L) Share Forecast, Price & News

GBX 31.80
0.00 (0.00 %)
(As of 11/5/2018)
Add
Compare
Today's Range
31.80
Now: GBX 31.80
31.80
50-Day Range
31.80
MA: GBX 31.80
31.80
52-Week Range
14.45
Now: GBX 31.80
32
Volume373,221 shs
Average Volume3.30 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.
Read More
Sinclair Pharma plc (SPH.L) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-74676920
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableOptionable
GBX 31.80
0.00 (0.00 %)
(As of 11/5/2018)
30 days | 90 days | 365 days | Advanced Chart

Receive SPH News and Ratings via Email

Sign-up to receive the latest news and ratings for SPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sinclair Pharma plc (SPH.L) (LON:SPH) Frequently Asked Questions

What stocks does MarketBeat like better than Sinclair Pharma plc (SPH.L)?

Wall Street analysts have given Sinclair Pharma plc (SPH.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sinclair Pharma plc (SPH.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Sinclair Pharma plc (SPH.L)'s key competitors?

What other stocks do shareholders of Sinclair Pharma plc (SPH.L) own?

Who are Sinclair Pharma plc (SPH.L)'s key executives?

Sinclair Pharma plc (SPH.L)'s management team includes the following people:
  • Mr. Christopher P. Spooner, CEO & Exec. Director
  • Mr. Alan Musgrave Olby, CFO & Director (Age 47)
  • Ms. Jayne Burrell, Group Gen. Counsel & Company Sec. (Age 43)
  • Ms. Emilie Croissant, Head of Europe & Global Marketing
  • Mr. Nairn McMaster, Head of Latin America

What is Sinclair Pharma plc (SPH.L)'s stock symbol?

Sinclair Pharma plc (SPH.L) trades on the London Stock Exchange (LON) under the ticker symbol "SPH."

How do I buy shares of Sinclair Pharma plc (SPH.L)?

Shares of SPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sinclair Pharma plc (SPH.L)'s stock price today?

One share of SPH stock can currently be purchased for approximately GBX 31.80.

What is Sinclair Pharma plc (SPH.L)'s official website?

The official website for Sinclair Pharma plc (SPH.L) is www.sinclairispharma.com.

How can I contact Sinclair Pharma plc (SPH.L)?

Sinclair Pharma plc (SPH.L)'s mailing address is 1st Fl Whitfield Court, 30-32 Whitfield Street, LONDON, W1T 2RQ, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-20-74676920.

This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.